Page last updated: 2024-09-05

sb 203580 and Ankylosing Spondylarthritis

sb 203580 has been researched along with Ankylosing Spondylarthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braem, K; Lories, RJ; Luyten, FP	1

Other Studies

1 other study(ies) available for sb 203580 and Ankylosing Spondylarthritis

Article	Year
Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo. Annals of the rheumatic diseases, 2012, Volume: 71, Issue:5 Topics: Animals; Ankylosis; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Chondrocytes; Chondrogenesis; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Imidazoles; Male; Mice; Mice, Inbred DBA; p38 Mitogen-Activated Protein Kinases; Periosteum; Pyridines; Signal Transduction; Smad Proteins; Spondylitis, Ankylosing; Transforming Growth Factor beta	2012

Article

Year

Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo.

Annals of the rheumatic diseases, 2012, Volume: 71, Issue:5

Topics: Animals; Ankylosis; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Chondrocytes; Chondrogenesis; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Imidazoles; Male; Mice; Mice, Inbred DBA; p38 Mitogen-Activated Protein Kinases; Periosteum; Pyridines; Signal Transduction; Smad Proteins; Spondylitis, Ankylosing; Transforming Growth Factor beta

2012